Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-16

Clinical Trial Update: The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating the effects of L-tyrosine supplementation on blood pressure in individuals with Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Tyrosine (L-tyrosine)

Snippet

Sponsor: New York Institute of Technology | Conditions: Parkinson's Disease | Phase 1, Phase 2 | Status: COMPLETED